AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
ProKidney Stock Soars 8.91% on Investor Interest
Generated by AI AgentAinvest Pre-Market Radar
Tuesday, Jun 24, 2025 9:26 am ET1min read
On June 24, 2025, ProKidney's stock surged by 8.91% in pre-market trading, marking a significant rise that has caught the attention of investors and analysts alike.
ProKidney Corp. (PROK) has been under scrutiny with its stock price forecast. As of the end of day on June 23, 2025, the price of a ProKidney Corp. share was $0.606. The 52-week high for ProKidney Corp. Stock is $2.59, indicating a wide range of price fluctuations over the past year.
ProKidney Corp. has been mentioned in the context of major holders, with Sutro Biopharma, Inc. (STRO) and MacroGenics, Inc. (MGNX) also being highlighted. This suggests that ProKidney is part of a broader investment landscape within the biopharmaceutical sector.
Ainvest Pre-Market Radar
Get the scoop on pre-market movers and shakers in the US stock market.
Latest Articles
AXT Inc. shares surge 13.35% on renewed earnings upside speculation amid supply chain adjustments
Dec.19 2025
PROK surged 5.11% on Dec. 19 2025 after HC Wainwright upgraded to Buy rating
Dec.19 2025
Tesla shares surge 3.45% as SpaceX orders 1,000-2,000 Cybertrucks for Starbase facility.
Dec.19 2025
Dingdong shares plunge 7.45% as pre-market sell-off sparks speculation over operational challenges
Dec.19 2025
Organogenesis Holdings Inc shares surged 9.49% on Dec. 19 2025 after FDA clears BLA submission for ReNu therapy
Dec.19 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet